OUR EDITORIAL RULES

Possibility is not proof.

We distinguish established care from emerging research, clinical trials and personal experiences so you can explore possibilities without confusing them.

The labels

Established

Strong research and/or authoritative clinical guidelines support this specific use.

Promising

Meaningful evidence exists for this use, but important questions remain—about size of benefit, who benefits, or long-term effects.

Emerging / limited

Early, small or mixed studies. Interesting, but not equivalent to established care.

In clinical trials

Being formally studied. Access is usually through a research study with its own eligibility rules and risks.

Experimental

Not established for routine use for this purpose. May be theoretical or in very early research.

Not recommended for this use

Authoritative guidance or regulators advise against this use, usually because of no benefit, real risk, or both.

Practical support

A service or life support. We describe what it offers; this is not a claim that it treats a condition.

Community-reported

One person’s experience, shared in What Helped Me. Not medical evidence.

Evidence and regulatory status are different.

FDA-approved medicine: authorized for a specific indication, age group and formulation. Approval does not prove it is better or safer than every existing option.

FDA-cleared device: cleared for a defined use; that does not authorize use for other diagnoses.

Promising clinical evidence: a meaningful study result may still involve unanswered questions, an unapproved drug or selected trial responders.

Investigational or experimental: under study, not available as routine approved treatment for the indicated use.

Safety concern or clinical hold: a meaningful regulatory risk signal requiring context and follow-up; a reported adverse event does not automatically prove causation.

Research-planning request: a regulator asking for data about future trials is not a new treatment approval.

See evidence and regulatory labels in News & Advances →

The rules behind them

  1. Every label is tied to a specific use. TMS is established for depression and experimental for autism; one badge never covers both.
  2. Every record shows who was studied, the regulatory status where relevant, cautions, and linked sources.
  3. Correcting a deficiency is not treating a condition. “Iron for documented iron deficiency” and “iron for ADHD symptoms” are separate entries.
  4. Community stories never become efficacy claims. We will not turn anecdotes into “87% say it works.”
  5. Goals before diagnoses. We never imply autism or any neurodevelopmental condition must be cured; co-occurring conditions are treated as their own questions.
  6. Health content is an editorial draft until clinically reviewed, and every page says so.

NeuroCoach is an educational and care-navigation resource, not a medical provider. Information about medications, supplements, therapies, devices, clinical trials and community experiences is provided for education and exploration and is not a recommendation, diagnosis or treatment plan. Evidence varies substantially among interventions. Decisions about medical or mental-health treatment should be made with an appropriately qualified healthcare professional. Do not start, stop or change medication, supplements or treatment based solely on information found here.

Our wider editorial approach